<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/26571?offset=1160</link>
	<atom:link href="https://bioinformaticsonline.com/related/26571?offset=1160" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/14218/pimp-your-brain-bioinformatics</guid>
	<pubDate>Wed, 20 Aug 2014 22:09:21 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/14218/pimp-your-brain-bioinformatics</link>
	<title><![CDATA[Pimp your brain: Bioinformatics]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/KqelGy6Q8nE" frameborder="0" allowfullscreen></iframe>Jan Lisec from the Max Planck Institute of Molecular Plant Physiology explains, in this "pimp your brain" episode, what bioinformatics is and why bioinformatics is so important and indispensable for biological research.

In the video serial "Pimp your brain" scientists from the Max Planck Institute of Molecular Plant Physiology describe their research. More videos from the 'Pimp your brain' serial are available on www.youtube.com/playlist?list=PL-l9VItC9Gn2Ur2Xj6PTOAkjLUlVPbIOO

More videos are available on www.mpimp-golm.mpg.de]]></description>
	
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/42470/the-new-corona-variant-has-23-mutations-in-all-which-is-unusually-huge</guid>
	<pubDate>Wed, 23 Dec 2020 03:50:50 -0600</pubDate>
	<link>https://bioinformaticsonline.com/news/view/42470/the-new-corona-variant-has-23-mutations-in-all-which-is-unusually-huge</link>
	<title><![CDATA[The new corona variant has 23 mutations in all, which is unusually huge !]]></title>
	<description><![CDATA[<p>The new SARS-CoV-2 version, B.1.1.7, which was first seen in the third week of September in Kent and Greater London, has since spread to other locations in the UK. According to the COVID-19 Genomics UK Consortium (COG-UK Consortium) that analysed the genome data of the virus and identified the variant, the new variant has been spreading "rapidly" over the last four weeks and has now been detected in other locations in the UK, suggesting further spread of the variant in the region.</p><p><span>According to a<span>&nbsp;</span></span><a href="https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563"><strong><span>preliminary report</span></strong></a><span><span>&nbsp;</span>posted on December 19 by the COG-UK Consortium scientists, as of December 15, 1,623 variant genomes have been sequenced. In a<span>&nbsp;</span></span><a href="https://twitter.com/TheCGPS/status/1340749351803629569"><strong><span>December 21 tweet</span></strong></a><span>, COG-UK Consortium said that it added 2,963 more genome sequences of SARS-CoV-2, of which 942 (32%) belong to the new variant. The Consortium<span>&nbsp;</span></span><a href="https://twitter.com/CovidGenomicsUK/status/1341073233420955654"><strong><span>intends to sequence</span></strong></a><span><span>&nbsp;</span>20,000 more SARS-CoV-2 genomes in the next two weeks to further ascertain the spread of the variant.</span></p><p><span>There is no clear proof, at least not yet, that it does cause severe pandemic. But there is a justification for seriously taking the possibility. Another coronavirus lineage in South Africa has acquired one specific mutation that is also present in B.1.1.7. This variant is increasingly spreading across South Africa's coastal regions. And doctors have observed in preliminary research that individuals infected with this variant bear a higher viral load-a higher concentration of the virus in their upper respiratory tract. In many viral diseases, this is associated with more severe symptoms.</span></p><p>&nbsp;</p>]]></description>
	<dc:creator>Shruti Paniwala</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/12989/center-for-molecular-dynamics-nepal-cmdn-nepal</guid>
  <pubDate>Wed, 23 Jul 2014 13:54:51 -0500</pubDate>
  <link></link>
  <title><![CDATA[Center for Molecular Dynamics Nepal (CMDN), Nepal]]></title>
  <description><![CDATA[
<p>Center for Molecular Dynamics Nepal (CMDN), established 2007 prides itself as a research driven nongovernmental organization. Unlike other civil society organizations, CMDN is dedicated entirely to promoting research in the country. With its team of energetic and highly motivated experts, CMDN is now recognized as the leading public health and wildlife research organization of the country.</p>

<p>More at http://www.cmdn.org.np/main/index.php</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/43362/machine-learning-for-genomics</guid>
	<pubDate>Thu, 09 Sep 2021 11:26:32 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/43362/machine-learning-for-genomics</link>
	<title><![CDATA[Machine Learning for Genomics]]></title>
	<description><![CDATA[<h3>Module 1: Statistics for genomics (2-8 August 2021)</h3>
<ul>
<li>A simple intro to statistical distributions</li>
<li>hypothesis testing</li>
<li>linear models.</li>
</ul>
<p>reading:&nbsp;<a href="http://compgenomr.github.io/book/stats.html">http://compgenomr.github.io/book/stats.html</a></p>
<p>slides:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/compgen2021_stats.pdf">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/compgen2021_stats.pdf</a></p>
<p>exercises+code:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week1/</a></p>
<h3><a href="https://github.com/BIMSBbioinfo/compgen2021#module-2-unsupervised-learning-for-genomics-9-15-august-2021"></a>Module 2: Unsupervised learning for genomics (9-15 August 2021)</h3>
<ul>
<li>Understanding basic intuition behind machine learning approaches.</li>
<li>Using unsupervised learning to cluster and visualise data points</li>
<li>Dimension reduction techniques for visualisation and as input to clustering methods</li>
</ul>
<p>reading:&nbsp;<a href="http://compgenomr.github.io/book/unsupervisedLearning.html">http://compgenomr.github.io/book/unsupervisedLearning.html</a></p>
<p>slides:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/compgen2021_unsupervisedLearning.pdf">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/compgen2021_unsupervisedLearning.pdf</a></p>
<p>exercises+code:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week2/</a></p>
<h3><a href="https://github.com/BIMSBbioinfo/compgen2021#module-3-supervised-learning-for-genomics-16-22-august-2021"></a>Module 3: Supervised learning for genomics (16-22 August 2021)</h3>
<ul>
<li>Understanding and using supervised learning methods for predictive purposes</li>
<li>How to measure prediction performance</li>
<li>Understand and use cross-validation and related concepts</li>
</ul>
<p>reading:&nbsp;<a href="http://compgenomr.github.io/book/supervisedLearning.html">http://compgenomr.github.io/book/supervisedLearning.html</a></p>
<p>slides:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/compgen2021_supervisedLearning.pdf">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/compgen2021_supervisedLearning.pdf</a></p>
<p>exercises+code:&nbsp;<a href="https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/">https://github.com/BIMSBbioinfo/compgen2021/tree/main/week3/</a></p>
<p>https://github.com/BIMSBbioinfo/compgen2021</p><p>Address of the bookmark: <a href="https://github.com/BIMSBbioinfo/compgen2021" rel="nofollow">https://github.com/BIMSBbioinfo/compgen2021</a></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/13267/the-genome-10k-project</guid>
	<pubDate>Tue, 29 Jul 2014 09:11:04 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/13267/the-genome-10k-project</link>
	<title><![CDATA[The Genome 10K Project]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/B57xDIGtCT0" frameborder="0" allowfullscreen></iframe>https://genome10k.soe.ucsc.edu

The Genome 10K project aims to assemble a genomic zoo—a collection of DNA sequences representing the genomes of 10,000 vertebrate species, approximately one for every vertebrate genus. The trajectory of cost reduction in DNA sequencing suggests that this project will be feasible within a few years. Capturing the genetic diversity of vertebrate species would create an unprecedented resource for the life sciences and for worldwide conservation efforts.

The growing Genome 10K Community of Scientists (G10KCOS), made up of leading scientists representing major zoos, museums, research centers, and universities around the world, is dedicated to coordinating efforts in tissue specimen collection that will lay the groundwork for a large-scale sequencing and analysis project.]]></description>
	
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/44412/scientist-positions-csir-institute-of-genomics-integrative-biology-igib</guid>
  <pubDate>Sat, 02 Dec 2023 00:51:08 -0600</pubDate>
  <link></link>
  <title><![CDATA[Scientist positions @ CSIR-Institute of Genomics &amp; Integrative Biology (IGIB)]]></title>
  <description><![CDATA[
<p>CSIR-Institute of Genomics &amp; Integrative Biology (IGIB) is a premier Institute of Council of Scientific<br />and Industrial Research (CSIR), engaged in research of national importance in the areas of genomics,<br />molecular medicine, bioinformatics and proteomics. For more details, kindly refer to website<br />https://igib.res.in.<br />The Institute is looking for dynamic and creative Indian researchers having excellent academic record<br />and interested in Product Development / Technology Innovation / Applied Technology / Translational<br />Research in the above broad areas. The eligible candidates may apply for the following positions<br />through the CSIR-IGIB website.</p>

<p>More at https://www.igib.res.in/bdmg/ScientistRecruitmentAdvt2023.pdf</p>
]]></description>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/13477/research-associate-at-indian-institute-of-chemical-technology-iict-hyderabad</guid>
  <pubDate>Thu, 07 Aug 2014 01:55:21 -0500</pubDate>
  <link></link>
  <title><![CDATA[Research Associate at Indian Institute of Chemical Technology (IICT), Hyderabad]]></title>
  <description><![CDATA[
<p>Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent of CSIR is a leading research Institute in the area of chemical sciences. The core strength of IICT lies in Organic Chemistry, and it continues to excel in this field for over six decades. The research efforts during these years have resulted in the development of several innovative processes for a variety of products necessary for human welfare such as drugs, agrochemicals, food, organic intermediates, adhesives etc. More than 150 technologies developed by IICT are now in commercial production.</p>

<p>CSIR-IICT is conducting Walk in Interview for the following position on a purely temporary basis for the sponsored project "GENESIS (BSC-0121) at 10.00 AM on 19th August 2014 at IICT, Hyderabad</p>

<p>    Position : Research Associate<br />    No of Post : One<br />    Desired Profile : PhD in computation biology or M.Tech in Computational Biology with three years experience in relevant subject and atleast one research paper in SCI journal</p>

<p>    Experience : Knowledge in vector and vector borne disease, disease modeling, GIS mapping and modeling.<br />    Age : 35 years<br />    Stipend : Rs 22000/- + HRA</p>

<p>Eligible candidate may download the application form from our website http://www.iictindia.org and appear for interview along with the duly filled in application form supported by bio-data and one set of attested photo copies of certificates of educational qualification, age, experience, caste, latest photograph and the cadndidates are required to bring all the original certificates for verification</p>

<p>Walk in Interview : 19.08.14</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/blog/view/44713/understanding-rna-seq-normalization-methods-tpm-vs-fpkm-vs-cpm</guid>
	<pubDate>Wed, 11 Dec 2024 00:59:15 -0600</pubDate>
	<link>https://bioinformaticsonline.com/blog/view/44713/understanding-rna-seq-normalization-methods-tpm-vs-fpkm-vs-cpm</link>
	<title><![CDATA[Understanding RNA-Seq Normalization Methods: TPM vs. FPKM vs. CPM]]></title>
	<description><![CDATA[<p>RNA sequencing (RNA-Seq) is a powerful technology used to study transcriptomes, providing insights into gene expression levels. However, raw RNA-Seq data requires normalization to account for sequencing depth and gene length, enabling accurate comparisons between genes and samples. Among the most widely used normalization methods are TPM (Transcripts Per Million), FPKM (Fragments Per Kilobase Million), and CPM (Counts Per Million). Each method has its unique principles and applications, which we&rsquo;ll explore in this blog.</p><h2>Why Normalize RNA-Seq Data?</h2><p>Normalization is a crucial step in RNA-Seq analysis for the following reasons:</p><ul>
<li>
<p><strong>Sequencing depth:</strong> Different RNA-Seq experiments produce varying numbers of reads, making direct comparisons between samples misleading.</p>
</li>
<li>
<p><strong>Gene length:</strong> Longer genes inherently generate more reads, irrespective of their actual expression level.</p>
</li>
<li>
<p><strong>Bias reduction:</strong> Normalization mitigates technical biases, enabling meaningful biological interpretation.</p>
</li>
</ul><h2>TPM (Transcripts Per Million)</h2><p>TPM measures the proportion of reads mapped to a transcript, normalized by transcript length and sequencing depth. It is calculated as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Proportionality:</strong> TPM values sum to 1,000,000 across all transcripts in a sample, making it easier to compare between samples.</p>
</li>
<li>
<p><strong>Intuitive interpretation:</strong> TPM values directly represent the abundance of transcripts in a sample.</p>
</li>
<li>
<p><strong>Preferred for comparisons:</strong> TPM facilitates between-sample comparisons better than FPKM.</p>
</li>
</ol><h2>FPKM (Fragments Per Kilobase Million)</h2><p>FPKM normalizes read counts by transcript length and sequencing depth, but without enforcing proportionality like TPM. It is defined as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Historical significance:</strong> FPKM was one of the first normalization methods used for RNA-Seq.</p>
</li>
<li>
<p><strong>Single-end vs. paired-end:</strong> In paired-end sequencing, FPKM becomes RPKM (Reads Per Kilobase Million).</p>
</li>
<li>
<p><strong>Limited utility:</strong> FPKM values are not as robust as TPM for cross-sample comparisons due to lack of proportionality.</p>
</li>
</ol><h2>CPM (Counts Per Million)</h2><p>CPM normalizes raw read counts by sequencing depth, without considering gene length. It is expressed as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Simplicity:</strong> CPM is straightforward and computationally less intensive.</p>
</li>
<li>
<p><strong>Application:</strong> Suitable for non-length-dependent analyses, such as comparing total expression levels or differential expression analysis.</p>
</li>
<li>
<p><strong>Gene length agnostic:</strong> CPM does not correct for gene length, making it less ideal for measuring expression levels.</p>
</li>
</ol><h2>When to Use Each Method</h2><ul>
<li>
<p><strong>TPM:</strong> Best for comparing expression levels between samples, especially when transcript length and sequencing depth vary.</p>
</li>
<li>
<p><strong>FPKM:</strong> Useful for historical consistency but generally replaced by TPM.</p>
</li>
<li>
<p><strong>CPM:</strong> Ideal for differential expression analysis when gene length normalization is unnecessary.</p>
</li>
</ul><h2>Conclusion</h2><p>Choosing the right normalization method depends on the specific objectives of your RNA-Seq analysis. TPM&rsquo;s proportionality and robustness make it the preferred choice for most applications, while CPM serves well for differential expression studies. Although FPKM paved the way for RNA-Seq normalization, it has largely been supplanted by TPM in modern workflows. Understanding these methods and their nuances ensures accurate and meaningful interpretations of RNA-Seq data.</p><h3>References:</h3><ol>
<li>
<p>Li, B., &amp; Dewey, C. N. (2011). RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. <em>BMC Bioinformatics.</em></p>
</li>
<li>
<p>Trapnell, C., et al. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. <em>Nature Biotechnology.</em></p>
</li>
<li>
<p>Law, C. W., et al. (2014). voom: precision weights unlock linear model analysis tools for RNA-seq read counts. <em>Genome Biology.</em></p>
</li>
</ol>]]></description>
	<dc:creator>Neel</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/3885/precision-medicine</guid>
	<pubDate>Sat, 24 Aug 2013 15:47:03 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/3885/precision-medicine</link>
	<title><![CDATA[Precision Medicine]]></title>
	<description><![CDATA[<p>Coupling established clinical&ndash;pathological indexes with state-of-the-art molecular profiling to create diagnostic, prognostic, and therapeutic strategies precisely tailored to each patient's requirements &mdash; hence the term &ldquo;Precision medicine&rdquo;&nbsp;</p>
<p>Source:<a href="http://www.nejm.org/doi/full/10.1056/NEJMp1114866">http://www.nejm.org/doi/full/10.1056/NEJMp1114866</a></p>
<p><strong>Another video on precision medicine</strong>:</p>
<p><a href="http://www.youtube.com/watch?v=Pi8W0yOXnzE">http://www.youtube.com/watch?v=Pi8W0yOXnzE</a></p>
<p>Precision Medicine basically intergrates bioinformatics, genomics , genetics, molecular biology and nanotechnology to deliver precise cure/diagnotics to a specific patient.</p>
<p>Examples:</p>
<ul>
<li><span>The drug imatinib (Gleevec) designed to inhibit an altered enzyme produced by a fused version of two genes found in chronic myelogenous leukemia.</span></li>
<li><span>The breast cancer drug trastuzumab (Herceptin) works only for women whose tumors have a particular genetic profile called HER-2 positive.</span></li>
</ul>
<p><span>E.g. source :</span></p>
<p><span><a href="http://www.bionews-tx.com/news/2013/08/15/how-the-impact-of-cancer-genomics-on-precision-medicine-is-revolutionizing-cancer-treatment/">http://www.bionews-tx.com/news/2013/08/15/how-the-impact-of-cancer-genomics-on-precision-medicine-is-revolutionizing-cancer-treatment/</a></span></p><p>Address of the bookmark: <a href="http://www.cbsnews.com/video/watch/?id=50149783n" rel="nofollow">http://www.cbsnews.com/video/watch/?id=50149783n</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/14054/project-fellow-at-institute-of-himalayan-bioresource-technology</guid>
  <pubDate>Fri, 15 Aug 2014 06:50:08 -0500</pubDate>
  <link></link>
  <title><![CDATA[Project Fellow at Institute of Himalayan Bioresource Technology]]></title>
  <description><![CDATA[
<p>Research Associate/ Project FellowDate of posting:14 Aug</p>

<p>Eligibility : MSc, M Phil / Phd, BE/B.Tech<br />Location : Himachal Pradesh-other<br />Job Category : Govt Jobs, Research, Walkin<br />Last Date : 20 Aug 2014</p>

<p>Advertisement No.6/2014</p>

<p>Post : Project Fellow<br />Research Associate/ Project Fellow Jobs opportunity in CSIR-Institute of Himalayan Bioresource Technology<br />M.Sc. in Bioinformatics/Computer Science with 55% marks and (ii) M.Sc. Bioinformatics/ Computational biology/ P.G. Diploma in Bioinformatics/B.Tech. or higher Degree in Bioinformatics with 55% marks</p>

<p>Date of Interview: 29.08.2014.</p>

<p>More at http://www.ihbt.res.in/recruit/AdvtNo6_2014.pdf</p>
]]></description>
</item>

</channel>
</rss>